1. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
- Author
-
Laura Edison, Gayle E Langley, Heidi R. Flori, Alexandra Edmundson, Aalok R. Singh, Kaitlin J. Jones, Adrienne G. Randolph, Dana Perella, Jenna Lifshitz, Michael Pietrowski, Lawrence C. Kleinman, Reed Magleby, Manish M. Patel, Phoebe H. Yager, Zunera Gilani, Karen S. Walker, Katherine K. Hsu, Sunanda Gaur, Margaret M Newhams, Brooke E. Hoots, Amanda B. Payne, Cole Burkholder, Matthew E. Oster, Sabrina M. Heidemann, Katharine N. Clouser, Saul R. Hymes, Sally Bidol, Neha Balachandran, Julie C. Fitzgerald, Ilana Harwayne-Gidansky, Kimberly L. Marohn, Ian Charpie, Rowan Walsh, Thomas S. Murray, Susan E. Coffin, Deepam Thomas, Angela P Campbell, Lynn E Sosa, Melissa Tobin-D’Angelo, Allison Longenberger, Cory Tice, Simon Li, Elizabeth Dufort, Justin Henderson, Shira J. Gertz, Angie M. Maxted, Maria Cecilia Di Pentima, John S. Giuliano, Monica L. Koncicki, Timmy Pierce, Dylan Leach, Keiko M. Tarquinio, Leora R. Feldstein, Dennis C. Coffey, Carrie Reed, Ermias D. Belay, Neal J. Thomas, Kate G. Ackerman, Shana Godfred-Cato, Jill M. Cholette, Neil D. Fernandes, Aaron T. Curns, Steven M. Horwitz, Christopher L. Carroll, Meagan Burns, Ryan W. Carroll, Troy Brancard, and F. Scott Dahlgren
- Subjects
Male ,Adolescent ,Population ,Ethnic group ,Rate ratio ,Cohort Studies ,Young Adult ,Age Distribution ,Interquartile range ,otorhinolaryngologic diseases ,Medicine ,Humans ,Young adult ,education ,Child ,Original Investigation ,education.field_of_study ,business.industry ,SARS-CoV-2 ,Incidence (epidemiology) ,Research ,Incidence ,Racial Groups ,COVID-19 ,General Medicine ,Systemic Inflammatory Response Syndrome ,United States ,Online Only ,Child, Preschool ,Pacific islanders ,Female ,Public Health ,business ,Demography ,Cohort study - Abstract
Key Points Question What was the incidence of multisystem inflammatory syndrome in children (MIS-C) among persons with SARS-CoV-2 infection in the US during April to June 2020? Findings In this cohort study of 248 persons with MIS-C, MIS-C incidence was 5.1 persons per 1 000 000 person-months and 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. Incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons compared with White persons and in younger persons compared with older persons. Meaning These findings suggest that MIS-C was a rare complication of SARS-CoV-2 infection; further study is needed to understand why MIS-C incidence varied by race/ethnicity and age group., This cohort study examines the incidence of multisystem inflammatory syndrome in children among persons in the US with SARS-CoV-2 infection., Importance Multisystem inflammatory syndrome in children (MIS-C) is associated with recent or current SARS-CoV-2 infection. Information on MIS-C incidence is limited. Objective To estimate population-based MIS-C incidence per 1 000 000 person-months and to estimate MIS-C incidence per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. Design, Setting, and Participants This cohort study used enhanced surveillance data to identify persons with MIS-C during April to June 2020, in 7 jurisdictions reporting to both the Centers for Disease Control and Prevention national surveillance and to Overcoming COVID-19, a multicenter MIS-C study. Denominators for population-based estimates were derived from census estimates; denominators for incidence per 1 000 000 SARS-CoV-2 infections were estimated by applying published age- and month-specific multipliers accounting for underdetection of reported COVID-19 case counts. Jurisdictions included Connecticut, Georgia, Massachusetts, Michigan, New Jersey, New York (excluding New York City), and Pennsylvania. Data analyses were conducted from August to December 2020. Exposures Race/ethnicity, sex, and age group (ie, ≤5, 6-10, 11-15, and 16-20 years). Main Outcomes and Measures Overall and stratum-specific adjusted estimated MIS-C incidence per 1 000 000 person-months and per 1 000 000 SARS-CoV-2 infections. Results In the 7 jurisdictions examined, 248 persons with MIS-C were reported (median [interquartile range] age, 8 [4-13] years; 133 [53.6%] male; 96 persons [38.7%] were Hispanic or Latino; 75 persons [30.2%] were Black). The incidence of MIS-C per 1 000 000 person-months was 5.1 (95% CI, 4.5-5.8) persons. Compared with White persons, incidence per 1 000 000 person-months was higher among Black persons (adjusted incidence rate ratio [aIRR], 9.26 [95% CI, 6.15-13.93]), Hispanic or Latino persons (aIRR, 8.92 [95% CI, 6.00-13.26]), and Asian or Pacific Islander (aIRR, 2.94 [95% CI, 1.49-5.82]) persons. MIS-C incidence per 1 000 000 SARS-CoV-2 infections was 316 (95% CI, 278-357) persons and was higher among Black (aIRR, 5.62 [95% CI, 3.68-8.60]), Hispanic or Latino (aIRR, 4.26 [95% CI, 2.85-6.38]), and Asian or Pacific Islander persons (aIRR, 2.88 [95% CI, 1.42-5.83]) compared with White persons. For both analyses, incidence was highest among children aged 5 years or younger (4.9 [95% CI, 3.7-6.6] children per 1 000 000 person-months) and children aged 6 to 10 years (6.3 [95% CI, 4.8-8.3] children per 1 000 000 person-months). Conclusions and Relevance In this cohort study, MIS-C was a rare complication associated with SARS-CoV-2 infection. Estimates for population-based incidence and incidence among persons with infection were higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons. Further study is needed to understand variability by race/ethnicity and age group.
- Published
- 2021